avodart
glaxosmithkline (ireland) limited - dutasteridas - minkštosios kapsulės - 0,5 mg - dutasteride
dutasteride elvim
sia elvim - dutasteridas - minkštosios kapsulės - 0,5 mg - dutasteride
dutasteride inteli
inteli generics nord, uab - dutasteridas - minkštosios kapsulės - 0,5 mg - dutasteride
atestur
pharmaswiss Česká republika s.r.o. - dutasteridas - minkštosios kapsulės - 0,5 mg - dutasteride
quedute
sandoz d.d. - dutasteridas - minkštosios kapsulės - 0,5 mg - dutasteride
quedute
sandoz d.d. - dutasteridas - minkštosios kapsulės - 0,5 mg - dutasteride
duprotens
teva pharma b.v. - dutasteridas - minkštosios kapsulės - 0,5 mg - dutasteride
reseligo
zentiva k.s. - goserelinas - implantas užpildytame švirkšte - 3,6 mg - goserelin
lutrate depot
angelini pharma Österreich gmbh - leuprorelinas - milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai - 22,5 mg; 3,75 mg - leuprorelin
xtandi
astellas pharma europe b.v. - enzalutamidas - prostatos navikai - endokrininė terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.